IL-6 administration at the start of resuscitation prevents HCC, reverses cardiac dysfunction, improves mortality and eliminates cardiomyocyte apoptosis, at least in part, through activation of Stat3 which acts to normalize the shock-induced apoptosis pathway transcriptome. Here, IL6 is linked to hepatocellular carcinoma.